Literature DB >> 10620637

More about: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

T R Rebbeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10620637     DOI： 10.1093/jnci/92.1.76

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Prostate cancer detection strategies.

Authors:  Timothy C Brand; Javier Hernandez; Edith D Canby-Hagino; Joseph W Basler; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2006-05       Impact factor: 3.092

2.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

Review 3.  Genetic polymorphisms and prostate cancer risk.

Authors:  Andrea Gsur; Elisabeth Feik; Stephan Madersbacher
Journal:  World J Urol       Date:  2003-11-26       Impact factor: 4.226

4.  Functional evaluation of genetic and environmental regulators of p450 mRNA levels.

Authors:  Dazhi Wang; Zhengwen Jiang; Zhongyang Shen; Hui Wang; Beilan Wang; Weihua Shou; Hong Zheng; Xun Chu; Jinxiu Shi; Wei Huang
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

5.  CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.

Authors:  M T Tayeb; C Clark; N E Haites; L Sharp; G I Murray; H L McLeod
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.